Carlo Agostini
Carlo Agostini
Head of Internal Medicine 1 & Clinical Immunology, Dep. of Medicine (TV) and DIMED, Padua University
Verified email at
Cited by
Cited by
Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus
GP Fadini, M Miorin, M Facco, S Bonamico, I Baesso, F Grego, ...
Journal of the American College of Cardiology 45 (9), 1449-1457, 2005
Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy
GP Fadini, S Sartore, M Albiero, I Baesso, E Murphy, M Menegolo, ...
Arteriosclerosis, thrombosis, and vascular biology 26 (9), 2140-2146, 2006
Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency
I Quinti, A Soresina, G Spadaro, S Martino, S Donnanno, C Agostini, ...
Journal of clinical immunology 27 (3), 308-316, 2007
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived …
GP Fadini, E Boscaro, M Albiero, L Menegazzo, V Frison, ...
Diabetes care 33 (7), 1607-1609, 2010
Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau
GP Fadini, I Baesso, M Albiero, S Sartore, C Agostini, A Avogaro
Atherosclerosis 197 (2), 496-503, 2008
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats
GP Fadini, S Sartore, M Schiavon, M Albiero, I Baesso, A Cabrelle, ...
Diabetologia 49 (12), 3075-3084, 2006
Autologous stem cell therapy for peripheral arterial disease: meta-analysis and systematic review of the literature
GP Fadini, C Agostini, A Avogaro
Atherosclerosis 209 (1), 10-17, 2010
Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk
GP Fadini, SV de Kreutzenberg, A Coracina, I Baesso, C Agostini, ...
European Heart Journal 27 (18), 2247-2255, 2006
Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population
GP Fadini, A Coracina, I Baesso, C Agostini, A Tiengo, A Avogaro, ...
Stroke 37 (9), 2277-2282, 2006
Endothelial progenitor cells in the natural history of atherosclerosis
GP Fadini, C Agostini, S Sartore, A Avogaro
Atherosclerosis 194 (1), 46-54, 2007
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection
C Agostini, F Calabrese, F Rea, M Facco, A Tosoni, M Loy, G Binotto, ...
The American journal of pathology 158 (5), 1703-1711, 2001
Sarcoidosis is a Th1/Th17 multisystem disorder
M Facco, A Cabrelle, A Teramo, V Olivieri, M Gnoato, S Teolato, E Ave, ...
Thorax 66 (2), 144-150, 2011
Involvement of the IP-10 chemokine in sarcoid granulomatous reactions
C Agostini, M Cassatella, R Zambello, L Trentin, S Gasperini, A Perin, ...
The Journal of Immunology 161 (11), 6413-6420, 1998
Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis.
C Agostini, L Trentin, M Facco, R Sancetta, A Cerutti, C Tassinari, ...
The Journal of Immunology 157 (2), 910-918, 1996
Significance of endothelial progenitor cells in subjects with diabetes
GP Fadini, S Sartore, C Agostini, A Avogaro
Diabetes care 30 (5), 1305-1313, 2007
Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study
I Quinti, A Soresina, A Guerra, R Rondelli, G Spadaro, C Agostini, C Milito, ...
Journal of clinical immunology 31 (3), 315-322, 2011
Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases
R Marcolongo, IM Tavolini, F Laveder, M Busa, F Noventa, P Bassi, ...
The American journal of medicine 116 (3), 194-197, 2004
Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis
C Agostini, C Gurrieri
Proceedings of the American Thoracic Society 3 (4), 357-363, 2006
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions
G Semenzato, F Pandolfi, T Chisesi, G De Rossi, G Pizzolo, R Zambello, ...
Cancer 60 (12), 2971-2978, 1987
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes
GP Fadini, E Boscaro, S De Kreutzenberg, C Agostini, F Seeger, ...
Diabetes care 33 (5), 1097-1102, 2010
The system can't perform the operation now. Try again later.
Articles 1–20